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Abstract: The properties of porous silicon make it a promising material for a host of 
applications including drug delivery, molecular and cell-based biosensing, and tissue 
engineering. Porous Silicon has previously shown its potential for the controlled release of 
pharmacological agents and in assisting bone healing. Hydroxyapatite, the principle 
constituent of bone, allows osteointegration in vivo, due to its chemical and physical 
similarities to bone. Synthetic hydroxyapatite is currently applied as a surface coating to 
medical devices and prosthetics, encouraging bone in-growth at their surface & improving 
osseointegration. This paper examines the potential for the use of an economically produced 
porous silicon particulate-polytetrafluoroethylene sheet for use as a guided bone regeneration 
device in periodontal and orthopaedic applications. The particulate sheet is comprised of a 
series of microparticles in a polytetrafluoroethylene matrix and is shown to produce a stable 
hydroxyapatite on its surface under simulated physiological conditions. The microstructure of 
the material is examined both before and after simulated body fluid experiments for a period 
of 1, 7, 14 and 30 days using Scanning Electron Microscopy. The composition is examined 
using a combination of Energy Dispersive X-ray Spectroscopy, Thin film X-ray diffraction, 
Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy and the 
uptake/release of constituents at the fluid-solid interface is explored using Inductively Coupled 
Plasma-Optical Emission Spectroscopy. Microstructural and compositional analysis reveals 
progressive growth of crystalline, ´bone-like´ apatite on the surface of the material, indicating 
the likelihood of close bony apposition in vivo.  
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1. Introduction 
Biomaterials are a select group of materials used for the medical treatment of the 
human body [1]. They can be either natural or synthetic materials which find 
application in a wide variety of medical and dental implants and prostheses used for 
repairing, enhancing or replacing natural tissues [2]. A key element of biomaterials is 
that they must provide physical support while maintaining compatibility with the host 
human organs and tissues [1]. Examples of clinical biomaterial applications today 
include joint replacements, bone grafts, vascular grafts and heart valves [2]. 
Bioceramics were first introduced to the world of orthopaedics during the 1960’s. 
These are classified into 3 types according to their tissue response; bio-inert 
(alumina and zirconia), bioactive (hydroxyapatite (HA) and bioglass) and 
bioresorbable (β tri-calcium phosphate (β-TCP) [3]. HA and bioglasses are generally 
used as bone graft substitutes and coatings on metallic implants due to their ability to 
elicit a strong interfacial reaction and bond with the host tissue [3]. Autografts and 
allografts remain the gold standard in graft surgery. However, issues including donor 
shortage and risk of infection make synthetic grafts an attractive option. Synthetic 
substances are more readily available and have greater sterility but the selection of 
grafting material is dependent on the nature and dimensions of the bone defects as 
well as choice of available grafts [3]. The treatment of bone defects, both small and 
large represents a great challenge for the orthopaedic and craniomaxiofacial fields.  
Guided bone regeneration (GBR) or guided tissue regeneration (GTR) is a 
specialised treatment concept which allows regeneration of osseous defects through 
the application of occlusive membranes at specific defect sites [4]. The main function 
of the membrane is to mechanically prevent the undesirable penetration of epithelial 
cells and fibroblasts to the bone defect area, creating a secluded space for bone 
regeneration to occur. The membrane barrier may also act to prevent infection and 
sepsis and acts as a replacement to a damaged periosteum. Covering defect sites 
with membranes enhances healing and is particularly useful in non-load bearing 
areas such as cranial and maxillofacial applications. Use of Polytetrafluoroethylene 
(PTFE) has shown to improve bone healing in numerous animal models [5-11]. 
Improved GBR membranes may also have applications in load-bearing orthopaedic 
applications, such as traumatic comminuted fractures, wherein the periosteum has 
been badly damaged or dissected. Used in combination with plates and pins, these 
devices could aid healing at such sites, preventing soft tissue ingress and allowing 
controlled release of osteogenic agents, such as strontium renelate or 
bisphosphonates. Current research has also shown the potential for a GBR-PTFE 
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membrane to aid in preventing wear particle induced osteolysis in orthopaedic 
implants by acting as a seal at the bone-cement interface [12].. The GBR products 
currently available in the market are GoreTex® (e-PTFE) (W.L. Gore & Assoc., 
Flagstaff, USA), Regencure (AMCA) and CollaGuide™(bovine-derived collagen type 
I), EpiGuide® (polylactic acid), Inion GTR™ (copolymer of L-lactic, D-lactic & glycolic 
acid) (Riemser Dental, New York, USA), Ossix™ (collagen) (OraPharma Inc., 
Warminster, USA), BioMend® (collagen) (Sultzer Calcitek Inc., Carlsbad, USA), 
Millipore filter® (cellulose ester) (Millipore Corp., Bedford, USA), Guidor (polylactic 
acid ester) (John O. Butler Co., Chicago, USA), Resolut (PLGA) (W.L. Gore & 
Assoc., Flagstaff, USA). However, none of these commercially available products 
enhance the growth rate of new bone or contain antibacterial properties. As a result, 
repair of mandibular bony defects remains a major problem in reconstructive surgery, 
with bone growth remaining slow [13].  
Silicon (Si), in its crystalline and nanostructured forms is now seen as a platform for 
tissue engineering, drug delivery, cell culture and interfacing cells with electronic 
devices [14-17]. Once exposed to physiological conditions, the native silicon hydride 
surface of Porous Silicon (PS) is slowly oxidised and degraded into silicic acid, the 
soluble form of Si, which is considered essential for normal bone development [18]. 
Si itself is thought to positively affect the cellular response at the implant-bone 
interface since Si is present in high concentration in metabolically active osteoblasts 
and considered critical in extracellular matrix formation in bone and cartilage [19]. 
Zhang et al. investigated the bone in-growth rate (BIR) of HA and Si-HA applied to a 
porous Ti material through a biomimetic coating process. The in vivo studies showed 
that the BIR of the HA and Si-HA coatings were significantly higher than the 
uncoated porous Ti and that the Si-HA coated porous Ti displayed significantly higher 
BIR and highly improved surface bioactivity than the HA coated porous Ti [20].  
Incorporating silicate ions into a HA structure has been suggested to enhance its rate 
of osteointegration [21-22]. It is now proposed that the development of a bioactive 
material containing Si-doped HA will induce a more rapid bone formation than phase-
pure HA, while also allowing enhanced cellular activity [19]. Given the drug and 
protein loading capabilities of PS, [23-26] there is the potential to develop an 
improved bioactive coating material which could also be loaded with growth factors, 
antibiotics or drugs capable of aiding bone healing or inducing a particular cell 
lineage at the implant site. In this study, a PS scaffold is investigated using simulated 
body fluid (SBF) experiments to examine its bioactivity in vitro. This scaffold is 
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produced from inexpensive Metallurgical Grade Silicon (MGSi) formed into a flexible 
tape using a Polytetrafluoroethylene (PTFE) fibrillation technique [27]. MGSi contains 
elements such as Fe, Al, Ca, C and O [28-29] which are likely segregated at grain 
boundaries of the silicon raw material [29]. Vesta Sciences (Monmouth 
Junction, New Jersey) has developed a patented chemical etching process [28, 30] 
which creates a high surface area nanoporous sponge-like structure in these 
particles [31,32]. The Metallurgical Grade Porous Silicon (MGPS) particles alone 
have been shown to induce a bioactive response in vitro [32], however, the 
combination of MGPS and PTFE into a membrane may represent a more suitable 
bioactive structure for grafting or coating applications. This paper is focused on the 
characterisation of this MGPS-PTFE membrane material, examining its composition 
and characterising its structure & morphology before and after in vitro experiments. 
Techniques including Scanning Electron Microscopy (SEM), Energy Dispersive X-ray 
Spectroscopy (EDX), Attenuated Total Reflectance-Fourier Transform Infrared 
Spectroscopy (ATR-FTIR), Inductively Coupled Plasma-Optical Emission 
Spectroscopy (ICP-OES) & Thin-film X-ray diffraction (XRD) were applied to the 
material. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
2. Experimental Details 
2.1 Porous Silicon Preparation 
Porous Silicon nanosponge particles were prepared by Vesta Sciences by chemical 
etching of 4E and 2E grade MGSi powder from Vesta Ceramics (Hisings Backa, 
Sweden) which is sold under the trademark of SicomillTM [28, 30]. The particles are 
chemically etched in a nitric-acid (NO3) - (HF) based mixture as described by Farrell 
et al. [28], which induces porosity within the MGSi particles. The composition of the 
chemical etchant is of HF:HNO3:H2O at a ratio ranging from about 4:1:20 to about 
2:1:10 by weight [28]. When the etching process is complete (i.e. photoluminescence 
is observed), the etched powder is removed from the acid bath and dried in 
perfluoroalkoxy (PFA) trays at 80°C for 24 hours. The result is the creation of PS 
sponge-like particles consisting of nanocrystals interspersed with 5-7nm diameter 
pores [28]. By varying the nitric acid concentration in the etchant mixture the surface 
area of these powders can also be tailored [28, 30]. The MGPS particles used in this 
study are referred to as grade 2E-100 and are developed from a grade 2E-Bulk MGSi 
material [31]. A similar grade of Si particles is used to develop the MGPS-PTFE 
membrane made from 4E Sicomill powders from Vesta Ceramics. 
 
2.2 Simulated Body Fluid 
A PTFE/MGPS membrane was supplied by Vesta Sciences. This membrane was 
produced by mixing ~10wt% PTFE beads (Dupont No.60 Teflon™) with PSi-E3 
porous silicon particles and a solvent. The mixture was extruded using a fibrillation 
technique to produce particles embedded in a PTFE fiber mat while preserving the 
nanoporous structure of the individual porous silicon particles and the surface area. 
The porous silicon particles were chemically etched in a similar fashion to sample 
2E-100 to produce high surface area powder. Particle size was around 4µm with the 
surface area at 157m2/g, pore volume at 0.3cc/g and pore size was an average of 
5.9nm. SBF was produced in accordance with published methods [31-32]. Reagents 
were dissolved in sequential order (as per Table 1) into 500 mL of purified water 
(Reagecon, Shannon, Ireland) using a magnetic stirrer. The solution was maintained 
at 36.5 ±1.5 ˚C using a water bath. One mole HCl was titrated to adjust the pH of the 
SBF to 7.40. Purified water was then added to adjust the total volume of liquid to one 
litre. Once prepared, the SBF was stored for 24 h (5 ˚C) to ensure that no 
precipitation occurred.  
 
Table 1: Order and amounts of reagents used to prepare 1,000 mL of SBF 
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Membrane structures were cut into appropriately sized samples and immersed in a 
calculated quantity of simulated body fluid (SBF), such that the following relationship 
was satisfied: Vs = Sa/10   
Where Vs is the volume of SBF (ml) and Sa is the surface area of the specimen 
(mm2). Specimens in SBF were stored in plastic containers and maintained at 
37±1˚C for 1, 7, 14 & 30 days. After removal from SBF, each sample was gently 
rinsed with purified water, placed on individually labelled sheets of filter paper and left 
in desiccators at room temperature to dry. After removal from SBF solutions, a 
Hitachi SU-70 scanning electron microscope (Hitachi High Technologies, America, 
Inc) was used to obtain secondary electron images and to carry out chemical 
analysis of the surface of the membrane. All EDX spectra were collected between 
15kV - 20 kV, using a beam current of 0.26 nA. Quantitative EDX converted the 
collected spectra into concentration data by using standard reference spectra 
obtained from pure elements under similar operating parameters. A Phillips Xpert 
MPD Pro 3040/60 X-ray Diffraction (XRD) Unit (Phillips, Amsterdam, Netherlands) 
was used to perform thin film XRD (TF-XRD) on the surface of the membranes after 
immersion in SBF to analyze the crystallinity of the CaP layer formed. TF-XRD was 
run between 25 and 45 degrees 2-theta, using a generator voltage of 40 Volts and a 
tube current of 40 Amps, a step size of 0.017 degrees 2-theta and a step time of 
40.72 s. A Varian 610-ATR-FTIR spectrometer was used to examine changes to the 
functional groups of the samples after each time period of immersion in SBF. 32 
ATR-FTIR scans were averaged between 4000 and 500 cm-1, with a resolution of 4 
cm-1. The SBF solutions, after removal of the membrane material, were filtered using 
Watman filter paper (1µm nominal pore size) and acidified (to maintain dissolution 
and prevent any re-precipitation during analysis) by making up 5 ml of SBF to 25 ml 
using 2 vol.% nitric acid. Standards were purchased (Reagecon, Shannon, Ireland) 
and suitably diluted, such that a linear correlation could be made within the range of 
the SBF samples. Inductively Coupled Plasma-Optical Emission Spectroscopy (ICP-
OES) was run on standards and samples and 2 vol. % nitric acid was used to clean 
out lines between runs.  
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2.3 Microscopy Analysis 
For high resolution SEM analysis the PS samples were spread onto a silver 
conducting paint on a 15 mm aluminum stub and loaded into the Hitachi SU-70 
scanning electron microscope. The MGPS-PTFE membrane was placed onto a 15 
mm aluminum stub and loaded into the SEM for analysis. In imaging mode, the SEM 
was operated at 3.0 kV with a sample working distance of 1.5-4 mm, while EDX 
analysis was performed at 15kV-20kV. 
 
3. Results & Discussion 
3.1 SEM of MGPS Particles 
The MGPS particles analysed had a porous layer up to 1 µm in thickness for 
particles measuring 4µm on average. This layer contains an interconnected network 
of disordered pore channels which run directly to the Si core of the particle which is 
about 2 µm in diameter [31]. Previous research on the PS material showed 
microstructural surface analysis of the pores and cross-sectional analysis of 
individual PS particles revealing pore depth [31]. Pore size for sample 2E-100 is on 
average 10-15nm. The SEM images in Fig. 1a show a selected PS particle from the 
MGPS powder sample with the surface porous microstructure displayed at higher 
magnification in the corresponding right image. Fig. 1b shows PS particle 
agglomeration and apatite-spherulite formation on the surface of the particles. The 
image on the right in Fig. 1b shows the needle-like structure of the apatite-spherulites 
at higher magnification. These apatite spherulites are similar to those observed by 
Canham in previous studies on porous silicon [34]. The needle-like morphology is 
indicative of HA and SEM-EDS analysis of the spherulites showed Ca/P ratios of 
1.67 which corresponds to stoichiometric HA. It is well known that bulk Si is 
considered a bioinert material with previous research showing no development of 
apatite in vitro. PS however, given its surface material properties is a more 
favourable candidate for apatite formation in SBF. Factors such as surface 
morphology, pore size, pore volume and presence of a surface oxide are considered 
essential requirements for apatite formation [34]. As a control sample a 
corresponding unetched 2E-Bulk Si silicon particulate material was placed into SBF 
for a period of 30 days, showing some particle agglomeration but no apatite 
formation on the sample once removed from SBF. The porous nature of the material 
and unique surface morphology appears to contribute to the apatite layer formed as 
was observed with similar grades of this material [32].  
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Fig. 1 SEM of the MGPS particles (a) before and after (b) immersion in SBF for 
14 days 
 
3.2 SEM of MGPS-PTFE Membrane 
As can be observed from Fig. 2, the MGPS particles are clearly visible within the 
PTFE matrix. SEM-EDX analysis revealed only the presence of Si and oxygen (O) 
(Fig. 3a) which are due to Si from the particles and O from the surface oxide on the 
particles. However, after immersion in SBF, the MGPS-PTFE membrane exhibits 
precipitation of a needle-like morphology on its surface after 14 days. EDX analysis 
reveals that this precipitate consists of Ca, P and Si, with small amounts of sodium 
(Na) and magnesium (Mg) incorporation (Fig. 3b). From the SEM analysis it was 
evident that the MGPS-PTFE membrane could induce the rapid formation of bone-
like apatite on its surface in SBF. This trial was conducted for a period of 1, 7, 14 and 
30 days. After 1 day in SBF a CaP layer began to develop on the surface of the 
membrane material. After 7 days the development of apatite spherulites with an 
apatite layer was more significant. Further growth continued up until 14 days when 
the entire surface of the material was completely covered in a CaP layer. At 30 days 
the spherulites ranged from 0.5-10µm in size.  
 
Fig. 2 SEM of the MGPS-PTFE membrane before (a) and after (b) immersion in 
SBF for 14 days 
Apatite spherulites fully formed on the MGPS-PTFE had Ca/P ratios consistent with 
HA (1.67). What is evident here is that the microstructural and elemental analysis 
show HA development after only 14 days in SBF outlining the ability of the 
membrane to induce rapid formation of HA on its surface in SBF within a very short 
timeframe. This result is favourable for any potential biomaterial or medical implant 
as the quicker the response for bone growth and tissue generation the faster the 
recovery time of the patient.  
 
Fig. 3 EDX analysis of MGPS-PTFE membrane before (a) and after (b) 
immersion in SBF 
 
3.3 TF-XRD of the MGPS-PTFE membrane 
TF-XRD of the fully etched sample, after immersion in SBF (Fig. 4), reveals that the 
surface precipitate is crystalline HA. It can be observed from Fig. 4 that after only 1 
day of immersion in SBF there is evidence of a small HA peak at approximately 26° 
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2-theta. This 100% HA peak continues to grow between 1 and 14 days of immersion, 
relative to the background Si peak, present at approximately 28.5° 2-theta.  
 
Fig. 4 TF-XRD of the MGPS-PTFE membrane at different immersion times in 
SBF 
 
3.4 ICP-OES of SBF at different periods 
ICP-OES analysis of the remaining SBF solutions after immersion studies indicated a 
linear reduction in Ca and P content with immersion time (Fig. 5), as might be 
expected with the surface precipitation of HA on the membrane. Potassium, sodium 
and magnesium remain relatively stable between 1 and 14 days. However, Si content 
in the solution was observed to increase after 1 day of immersion and linearly 
decrease thereafter. This would indicate that initial degradation of the Si particles 
occurs, followed by a silicon uptake by the precipitating HA. This indicates that the 
initial HA precipitation observed (after 1 day) may be either Si free or have a low Si 
content, followed thereafter (7 & 14 days) by precipitation of a Si-rich HA phase. This 
initial Si release into solution, as well as the subsequent uptake in the HA structure 
will likely be beneficial from a therapeutic perspective. These results may indicate 
that if incorporating pharmacological or biological components into this material by 
tethering to the silicon surface that a high initial release is likely. Inclusion of the 
agent within the porous structure by capping may be more beneficial.  
 
Fig. 5 ICP-OES of SBF after different periods of MGPS-PTFE membrane 
immersion 
 
3.5 ATR-FTIR of the MGPS-PTFE membrane 
ATR-FTIR spectroscopy results show typical transmission peaks for the PTFE 
material (without silicon particles) and no variation was observed after immersion in 
SBF for 30 days. The silicon-PTFE membrane exhibits peaks relating to silicon, the 
most notable being at c.1022 cm-1, as can be observed in Fig 6 after 1 day of 
immersion in SBF. A shoulder can also be observed on this peak, which may be due 
to overlap with the PTFE binding material. 7, 14 and 30 day samples exhibit a 
reduction, or masking, of these peaks, which may be due to the growth of a surface 
precipitate. Any phosphate stretching would likely be masked by the presence of the 
broad silicon peak at 1022 cm-1, which would occur in the same spectral region. 
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Fig. 6 ATR-FTIR analysis of the MGPS-PTFE membrane after different time 
periods of immersion in SBF 
 
4. Discussion 
PS has the potential to serve as a biomaterial with a wide range of applications. It 
has both tunable and controllable surface properties and characteristics favouring the 
material ahead of most other potential applications. It has already been shown to be 
biocompatible, biodegradable and can assist in tailoring current market biomaterials 
and surface coatings to have improved bioactivity both in vitro and in vivo. PS is 
under investigation for use as a potential material for drug delivery and therapeutics 
given its unique properties including high drug loading capacity, heat and radiation 
stability, in vivo biocompatibility and controlled release properties [23]. The low 
toxicity of PS and its tunable surface chemistry has created a surge of interest in 
developing PS as a potential mother-ship for therapeutics, diagnostics and other 
types of payloads [25, 35].  
 
Previous studies have examined the effects of HA and Si-HA coatings applied to 
porous Ti [20]. The HA and Si-HA coatings were applied to the porous Ti through a 
biomimetic coating process. In vivo studies showed that the Bone In-Growth rate 
(BIR) of the HA and Si-HA coatings were significantly higher than the uncoated 
porous Ti and that overall the Si-HA coated porous Ti displayed significantly higher 
BIR and highly improved surface bioactivity than the HA coated porous Ti [20]. Si is 
shown to be concentrated in the active bone growth sites of young mice and rats (co-
localized with osteoblasts) and increased together with the level of Ca in osteoid 
tissues [35]. Thian et al. investigated the in vitro bioactivity of Si-doped HA coatings 
applied to a Ti substrate through magnetron co-sputtering in SBF. When comparing 
the as-sputtered HA (control sample) and Si-doped HA coatings it was revealed that 
a denser precipitated layer formed on Si-doped HA showing improved bioactivity 
compared to the as-sputtered HA material [36]. The increased bioactivity of the Si-
doped HA can be attributed to the chemical reactions between the SBF and the 
coating material. During the initial dissolution phase Ca (Ca2+) and P (P5+) ions are 
released into the SBF which increases the degree of super-saturation of SBF with 
respect to apatite [37]. This facilitates the initial formation of CaP nuclei on the 
coating surface by consuming the Ca2+ and P5+ in the SBF. CaP crystallite growth 
results in combination with the formation of additional nuclei creating a surface 
apatite layer [37].  
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MGSi powder contains trace levels of impurities such as Fe, Al, Ca, C and O [27] 
which are a result of the smelting and grinding process applied to make the MGSi 
powder [28]. Some of these impurities like Al likely play a role in the chemical etching 
process that leads to pore formation through their influence on doping. The porous 
silicon particles used in this study consist of an outer porous shell ~ 1 micron thick 
with a solid Si core remaining at the particle centre. In PS particles, which are less 
than 2µm in size the porous structure extends through the particle [31]. 
The MGPS-PTFE material in this study has the potential to be used as a drug vehicle 
given its tunable surface porosity and surface pore characteristics and could be 
further tailored to accommodate specific drug molecules or growth factors which 
could enhance or promote wound healing and blood vessel and tissue regeneration 
upon implantation [38]. It has already shown the ability to rapidly develop HA 
formation in vitro making it both bioactive and showing the potential bone bonding 
ability. 
This bioactive material could also pave the way for an improved type of GBR device 
which might not only induce a more rapid form of HA development and induce rapid 
bone bonding at the implant interface but could also deploy specific growth factors or 
drugs to stimulate further bone healing and repair. Current GBR devices are not 
bioactive, and though many bioactive GBR devices, containing HA or bioactive glass 
particles have been investigated in the literature, these do not have the potential to 
deliver high payloads of pharmacological or biological agents, which will be required 
for the next generation of tissue engineered and therapeutic biomaterials.  
 
5. Conclusions 
The work presented here characterises a bioactive MGPS-PTFE material which has 
the potential to be further developed for suitable bone bonding applications or a 
guided bone regeneration device.  The membrane material was examined after SBF 
trials and initiated deposition of a ‘bone-like apatite’ on its surface after only 14 days 
of immersion in simulated body fluid. This ‘bone-like apatite’ contains Si incorporated 
into its structure, which is known to improve apatite’s biocompatibility and results in 
increased cellular differentiation and bone growth. Due to its reactivity in vitro and its 
nanoporous sponge structure, this material exhibits potential for use in bony 
applications, as well as in drug delivery device applications. Drug delivery devices 
may also be used as an enhanced bioactive platform for the incorporation and 
delivery of various pharmacological and biological agents in vivo. 
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Table 1: Order and amounts of reagents used to prepare 1,000 mL of SBF 
Order Reagent Quantity 
1  NaCl 8.035 g 
2  NaHCO3 0.355 g 
3  KCl 0.225 g 
4  K2HPO4.3H2O 0.231 g 
5  MgCl2.6H2O 0.311 g 
6  1.0 M-HCl 39 mL 
7  CaCl2 0.292 g 
8  Na2SO4 0.072 g 
9  Tris 6.118 g 
10  1.0 M-HCl 0–5 mL 
 
  
 
